April - 2020
| Previous Next | Showing Journal 8 of 10 |
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19Muthiah Vaduganathan, M.D., M.P.H., Orly Vardeny, Pharm.D., Thomas Michel, et al NEJM, 2020, Online first This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
April |
Previous Comments
No Comments yet.
Comment
Most of us will have heard about the interplay of Covid-19, the renin-angiotensin-aldosterone system (RAAS), and angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin-receptor blockers (ARBs). We are paying intention because our patients and many of...